University of California San Francisco
Give to UCSF
UCSF's Global Health Sciences is launching a new project to improve care for women in India and Kenya, called the Strengthening People-centered Accessibility, Respect, and Quality (SPARQ) project, funded by the Bill and Melinda Gates Foundation and The David and Lucile Packard Foundation.
UCSF researchers has discovered that single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.
UCSF researchers have found a human gene that could one day allow physicians to correct congenital deformities, regrow damaged fingers, or even mend a broken heart.
An international team of scientists led by UCSF researchers has mapped out the genetic trajectories taken by melanoma as it evolves from early skin lesions, known as precursors, to malignant skin cancer.
UCSF has launched a collaboration with international pharmaceutical company GlaxoSmithKline plc (GSK) to promote early-stage research with the potential to translate into new therapies for cancer, obesity and antibiotic resistant bacteria.
In Mali, a new approach to patient care aims to decrease the nation's childhood mortality rate.
A coalition of leukemia researchers led by scientists from UCSF has discovered surprising genetic diversity in juvenile myelomonocytic leukemia (JMML), a rare but aggressive childhood blood cancer.
Gay and bisexual men were up to six times more likely than heterosexual men to take part in indoor tanning, and twice as likely to report a history of skin cancer, according to a study led by UCSF researchers.
Online advertising based on Google search terms is a potentially effective way to deliver targeted cancer prevention education, according to a study led by Eleni Linos, MD, DrPH, assistant professor of dermatology at UCSF.
Adolescents and adults under 40 who have been successfully treated for cancer are at heightened risk of developing a second unrelated cancer, on average 15 years later, according to a study.
UCSF researchers have engineered a molecular “on switch” that allows tight control over the actions of T cells, immune system cells that have shown great potential as therapies for cancer.
UCSF scientists describe capturing and studying individual metastatic cells from human breast cancer tumors implanted into mice as the cells escaped into the blood stream and began to form tumors elsewhere in the body.
Zev Gartner is working to building a fully functioning 3-D human breast tissue that will allow him to test potential cancer therapies, an innovation that's earned him a spot among Popular Science's "Brilliant 10" this year.
